Cargando…

Acceptability of Multiparticulate Dosing Using Sympfiny(®) Delivery System with Children (Age 1–12)

This study investigated multiparticulate formulation administered over a two-week period of time via the Sympfiny(®) system with children of ages 1–12 years. The study was conducted with parent–child pairs (N = 120 total participants) following a specific dose strategy to mimic PURIXAN’s dosing guid...

Descripción completa

Detalles Bibliográficos
Autores principales: Abeln, Kate, Cox, Kate, Haggerty, Laura, Privitera, Mary Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698589/
https://www.ncbi.nlm.nih.gov/pubmed/36432715
http://dx.doi.org/10.3390/pharmaceutics14112524